Yarrow Bioscience YARW
NASDAQ YARW
$29.11 -0.19 (-0.65%)
At close: Sep 9, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Minority Interest (2022)

Yarrow Bioscience's (YARW) quarterly Minority Interest came in at $211000.0 in Q4 2022.

Analysis

Yarrow Bioscience (YARW) Minority Interest (2022) Analysis & Trends

Yarrow Bioscience (YARW) has reported Minority Interest for 1 consecutive years, with $211000.0 the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Minority Interest changed N/A year-over-year to $211000.0; the trailing twelve-month figure through Dec 2022 stood at $211000.0 (changed N/A YoY), and the FY2022 full-year result was $211000.0, changed N/A from the prior year.
  • Minority Interest steadied at $211000.0 in Q4 2022 per YARW's latest filing.
  • Across five years, Minority Interest topped out at $211000.0 in Q4 2022 and bottomed at $211000.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Yarrow Bioscience 25.92 Mn 3.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 211,000.00